Bristol-Myers Squibb Co

BMY72

S&P500

$57.85arrow_drop_down0.05%-$0.03

S&P500

BMY72

$57.85

arrow_drop_down0.05%-$0.03

S&P500

Performance History

Key Stats
Open	$58.60
Prev. Close	$58.23
EPS	-3.58

Next Earnings Date	Feb 3, 2025


PE Ratio	-

	LOW	HIGH
Day Range	57.67	58.73
52 Week Range	39.35	62.22

Ratios







EPS	-3.58

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Bristol-Myers Squibb Co (BMY)

Bristol-Myers Squibb Co (BMY) is a global biopharmaceutical company that focuses on discovering, developing, and delivering innovative medicines to help patients prevail over serious diseases. With a rich history spanning over 130 years, Bristol-Myers Squibb has built a reputation for delivering high-quality pharmaceuticals that make a difference in patients' lives. The company's portfolio includes a broad range of therapeutic areas, including oncology, cardiovascular disease, immunology, and fibrotic disease. Bristol-Myers Squibb's commitment to scientific innovation and patient-centricity has made it a trusted partner in the healthcare industry.

In recent news, Bristol-Myers Squibb announced positive results from clinical trials for a promising cancer treatment. The drug has shown significant efficacy in treating certain types of tumors, and the company plans to seek regulatory approval for its use. This breakthrough has generated excitement among investors, leading to an increase in the company's stock price. Analysts believe that if approved, this drug could become a blockbuster product and drive substantial revenue growth for Bristol-Myers Squibb.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—General
CEO: Dr. Giovanni Caforio M.D.
Headquarters: New York
Employees: 34300
Exchange: NYSE

add Bristol-Myers Squibb Co to watchlist

Keep an eye on Bristol-Myers Squibb Co

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Bristol-Myers Squibb Co's (BMY) price per share?

The current price per share for Bristol-Myers Squibb Co (BMY) is $57.85. The stock has seen a price change of -$0.03 recently, indicating a -0.05% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Bristol-Myers Squibb Co (BMY)?

For Bristol-Myers Squibb Co (BMY), the 52-week high is $62.22, which is 7.56% from the current price. The 52-week low is $39.35, the current price is 47.01% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Bristol-Myers Squibb Co (BMY) a growth stock?

Bristol-Myers Squibb Co (BMY) has shown an average price growth of -7.23% over the past three years. It has received a score of 59 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Bristol-Myers Squibb Co as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Bristol-Myers Squibb Co (BMY) stock price performance year to date (YTD)?

As of the latest data, Bristol-Myers Squibb Co (BMY) has a year-to-date price change of 9.65%. Over the past month, the stock has experienced a price change of 10.99%. Over the last three months, the change has been 18.11%. Over the past six months, the figure is 33.42%. Looking at a longer horizon, the five-year price change stands at 2.55%.

help

Is Bristol-Myers Squibb Co (BMY) a profitable company?

Bristol-Myers Squibb Co (BMY) has a net income of $8.04B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 76.24% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 18.48% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $45.01B, although specific revenue growth data is currently not available. The gross profit is $34.31B. Operating income is noted at $16.6B. Furthermore, the EBITDA is $18.41B.

help

What is the market capitalization of Bristol-Myers Squibb Co (BMY)?

Bristol-Myers Squibb Co (BMY) has a market capitalization of $117.39B. The average daily trading volume is 57.9, indicating the stock's liquidity and investor engagement.